Drug Patent Expirations for the Week of March 31, 2024
EXSERVAN (riluzole) Aquestive Patent: 8,603,514 Expiration: Apr 3, 2024 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or visit…![](https://www.drugpatentwatch.com/blog/wp-content/plugins/matomo/app/matomo.php?idsite=1&rec=1&url=https%3A%2F%2Fwww.drugpatentwatch.com%2Fblog%2Fdrug-patent-expirations-for-the-week-of-march-31-2024%2F&action_name=Drug%20Patent%20Expirations%20for%20the%20Week%20of%20March%2031%2C%202024&urlref=https%3A%2F%2Fwww.drugpatentwatch.com%2Fblog%2Ffeed%2F)